Adjunctive brexpiprazole for elderly patients with major depressive disorder: An open‐label, long‐term safety and tolerability study

OBJECTIVES: The objective of this study was to evaluate the long‐term safety and tolerability of flexible‐dose brexpiprazole adjunct to antidepressant treatment (ADT) in elderly patients with major depressive disorder (MDD). METHODS: Elderly patients (≥65 years) with MDD and inadequate response to ≥...

Descripción completa

Detalles Bibliográficos
Autores principales: Lepola, Ulla, Hefting, Nanco, Zhang, Doris, Hobart, Mary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175103/
https://www.ncbi.nlm.nih.gov/pubmed/30039634
http://dx.doi.org/10.1002/gps.4952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175103/
https://www.ncbi.nlm.nih.gov/pubmed/30039634
http://dx.doi.org/10.1002/gps.4952

Ejemplares similares